UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

BMC infectious diseases, 2012-02, Vol.12 (1), p.38-38, Article 38

2012

Volltextzugriff (PDF)

Relationship between body mass index and bone mineral density in HIV‐infected patients referred for DXA

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19569-n/a

2014

Volltextzugriff (PDF)

Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e629-e637

2023

Volltextzugriff (PDF)

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

Journal of acquired immune deficiency syndromes (1999), 2007-06, Vol.45 (2), p.174-182

2007

Volltextzugriff (PDF)

Chlamydial Infection Mimicking Rectal Neoplasia: An Uncommon Diagnosis Complicated by the Interference of Drugs Used for the Treatment of Symptoms

Journal of clinical & experimental pathology, 2018, Vol.8 (6)

2018

Volltextzugriff (PDF)

Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2006-03, Vol.41 (3), p.332-337

2006

Volltextzugriff (PDF)

Novel Antiretroviral Drugs and Renal Function Monitoring of HIV Patients

AIDS reviews, 2014-09, Vol.16 (3), p.1-1

2014

Volltextzugriff (PDF)

Simplification to co‐formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19812-n/a

2014

Volltextzugriff (PDF)

Central nervous system penetration‐effectiveness rank does not reliably predict neurocognitive impairment in HIV‐infected individuals

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19655-n/a

2014

Volltextzugriff (PDF)

Prospective evaluation of bone markers, parathormone and 1,25

BMC infectious diseases, 2012-02, Vol.12, p.38

2012

Volltextzugriff (PDF)

Prospective evaluation of bone markers, parathormone and 1,25-.sub.2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

BMC infectious diseases, 2012-02, Vol.12, p.38

2012

Volltextzugriff (PDF)

Relación entre la amplificación del oncogén C-erbB-2 y parámetros histológicos con sobrevida libre de enfermedad en pacientes con cáncer de mama

Revista medíca de Chile, 2005-02, Vol.133 (2), p.151-157

2005

Volltextzugriff (PDF)

Erratum-II

Current medicinal chemistry, 2008-12, Vol.15 (30), p.3280-3280

2008

Volltextzugriff (PDF)

Stable Virologic Suppression during Raltegravir plus Atazanavir Dual-Therapy Taken Every other Day: A Case Report

Journal of AIDS & clinical research, 2012, Vol.1 (S2)

Gentilotti, Elisa

2012

Volltextzugriff (PDF)

Managing patients with sexual transmission of drug-resistant HIV

Sexual health, 2005, Vol.2 (3), p.135

2005

Volltextzugriff (PDF)

Specific mutations in HIV-1 g41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Journal of antimicrobial chemotherapy, 2006, Vol.58 (4), p.714-722

2006

Volltextzugriff (PDF)

Mutations in HIV-l Reverse Transcriptase Potentially Associated with Hypersusceptibility to Nonnucleoside Reverse-Transcriptase Inhibitors: Effect on Response to Efavirenz-Based Therapy in an Urban Observational Cohort

The Journal of infectious diseases, 2004-05, Vol.189 (9), p.1688-1695

2004

Volltextzugriff (PDF)

Relationship of oncogene C-erbB-2 amplification in breast cancer with pathological parameters and disease free survival

Revista medíca de Chile, 2005-02, Vol.133 (2), p.151-157

2005

Volltextzugriff (PDF)

Niveles séricos de cobre en pacientes: con enfermedad benigna y cáncer de mama

Revista venezolana de oncología, 2005-01, Vol.17 (1), p.18-24

2005

Volltextzugriff (PDF)

Relationship Between Health-Related Quality of Life Measures and High HIV Viral Load in HIV-Infected Triple-Class-Experienced Patients

HIV Clinical Trials, 2014, Vol.15 (4), p.176-183

2014

Volltextzugriff (PDF)

A rare case of severe myopathy associated with etravirine use

AIDS (London, England), 2010, Vol.24 (7), p.1088-1090

2010

Volltextzugriff (PDF)

Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety

AIDS (London, England), 2010, Vol.24 (7), p.1083-1084

2010

Volltextzugriff (PDF)

Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir

Scandinavian Journal of Infectious Diseases, 2010, Vol.42 (3), p.237-239

2010

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(25)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(7)
Hiv
(6)
Highly Active Antiretroviral Therapy
(5)
Human Immunodeficiency Virus
(5)
Aids
(4)
Aids/hiv
(4)
Female
(4)
Hiv Infection
(4)
Hiv Infections - Drug Therapy
(4)
Osteoporosis
(4)
Acquired Immune Deficiency Syndrome
(3)
Anti-Hiv Agents - Administration & Dosage
(3)
Antiretroviral Drugs
(3)
Biological And Medical Sciences
(3)
Health Aspects
(3)
Hiv Infections - Complications
(3)
Hiv Patients
(3)
Human Viral Diseases
(3)
Infectious Diseases
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

10 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

Relationship between body mass index and bone mineral density in HIV‐infected patients referred for DXA

Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count

Chlamydial Infection Mimicking Rectal Neoplasia: An Uncommon Diagnosis Complicated by the Interference of Drugs Used for the Treatment of Symptoms

Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy

Novel Antiretroviral Drugs and Renal Function Monitoring of HIV Patients

Simplification to co‐formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Central nervous system penetration‐effectiveness rank does not reliably predict neurocognitive impairment in HIV‐infected individuals

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

Prospective evaluation of bone markers, parathormone and 1,25

Prospective evaluation of bone markers, parathormone and 1,25-.sub.2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

Relación entre la amplificación del oncogén C-erbB-2 y parámetros histológicos con sobrevida libre de enfermedad en pacientes con cáncer de mama

Erratum-II

Stable Virologic Suppression during Raltegravir plus Atazanavir Dual-Therapy Taken Every other Day: A Case Report

Managing patients with sexual transmission of drug-resistant HIV

Specific mutations in HIV-1 g41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Mutations in HIV-l Reverse Transcriptase Potentially Associated with Hypersusceptibility to Nonnucleoside Reverse-Transcriptase Inhibitors: Effect on Response to Efavirenz-Based Therapy in an Urban Observational Cohort

Relationship of oncogene C-erbB-2 amplification in breast cancer with pathological parameters and disease free survival

Niveles séricos de cobre en pacientes: con enfermedad benigna y cáncer de mama

Relationship Between Health-Related Quality of Life Measures and High HIV Viral Load in HIV-Infected Triple-Class-Experienced Patients

A rare case of severe myopathy associated with etravirine use

Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety

Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir

Aktive Filter

Suchergebnisse filtern